Cargando…

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes

Cellular senescence is a cellular state with a broad spectrum of age-related physiological conditions that can be affected by various infectious diseases and treatments. Therapy of hepatitis B virus (HBV) infection with nucleos(t)ide analogs [NA(s)] is well established and benefits many HBV-infected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takamatsu, Yuki, Hayashi, Sanae, Kumamoto, Hiroki, Imoto, Shuhei, Tanaka, Yasuhito, Mitsuya, Hiroaki, Higashi-Kuwata, Nobuyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194405/ https://www.ncbi.nlm.nih.gov/pubmed/36933835 http://dx.doi.org/10.1016/j.virusres.2023.199094

Ejemplares similares

Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application
por: Hayashi, Sanae, et al.
Publicado: (2022)

Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent
por: Kumamoto, Hiroki, et al.
Publicado: (2023)

Drug Discovery Study Aimed at a Functional Cure for HBV
por: Watanabe, Takehisa, et al.
Publicado: (2022)

The Interactions Between HBV and the Innate Immunity of Hepatocytes
por: Megahed, Fayed Attia Koutb, et al.
Publicado: (2020)

HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir
por: Yasutake, Yoshiaki, et al.
Publicado: (2018)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2
por: Nakanishi, Anna, et al.
Publicado: (2022)

Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine
por: Amano, Masayuki, et al.
Publicado: (2022)

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
por: Yan, Ran, et al.
Publicado: (2015)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes
por: Huang, Chien-Jung, et al.
Publicado: (2021)

Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
por: de Beijer, Monique T.A., et al.
Publicado: (2022)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes
por: Ancey, Pierre-Benoit, et al.
Publicado: (2015)

ACE2 and TMPRSS2 Expression in Hepatocytes of Chronic HBV Infection Patients
por: Hu, Xiao-Xiao, et al.
Publicado: (2021)

ATOH8 promotes HBV immune tolerance by inhibiting the pyroptotic pathway in hepatocytes
por: Liu, Xiaofei, et al.
Publicado: (2023)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma
por: Mani, Saravana Kumar Kailasam, et al.
Publicado: (2020)

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study
por: Ma, Haiyan, et al.
Publicado: (2021)

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings
por: Tricot, Tine, et al.
Publicado: (2022)

Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?
por: Beudeker, Boris J.B., et al.
Publicado: (2021)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018)

Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B
por: Hu, Gang, et al.
Publicado: (2021)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Manske, Katrin, et al.
Publicado: (2021)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Occult HBV infection
por: Raimondo, Giovanni, et al.
Publicado: (2012)

HBV Perinatal Transmission
por: Umar, Muhammad, et al.
Publicado: (2013)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_etornagq0b1gdi17nt9lqff8k6